| 10/19/2021 |
HLTH21: Roche, Ibex Medical Partner to Develop AI-Powered Digital Pathology Apps |
HIT Consultant |
... integrating its Galen™ platform into Roche’s uPath enterprise cloud software in order to help pathologists to enable pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology, the cloud version of Roche’s uPath enterprise software. Pathologists play a crucial role in the detection and diagnosis of cancer, but a rise in cancer prevalence and a shrinking number of pathologists worldwide ... |
| 10/18/2021 |
INIFY Prostate® shown to accurately outline suspicious |
Globe Newswire |
STOCKHOLM – October 18, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology , today announced that results from a US clinical evaluation were presented at the Pathology Visions Congress in Las Vegas, USA.The evaluation was performed together with two independent pathologists, Anil Parwani, M.D., Ph.D., M.B.A. at Ohio State University Comprehensive Cancer Center (Columbus, Ohio), and Ming ... |
| 10/18/2021 |
Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care |
roboticulized.com |
... intelligence (AI)-based cancer diagnostics. Under the agreement, the companies will jointly develop an embedded image analysis workflow for pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology, the cloud version of Roche’s uPath enterprise software. Collaborations with leading AI companies like Ibex are made possible through Roche’s Digital Pathology Open Environment, which allows pathologists to securely access third-party ... |
| 10/18/2021 |
Roche announces collaboration with Ibex Medical Analytics |
indiamedtoday.com |
To develop artificial intelligence-based digital pathology applications for improved patient care Roche has entered an agreement with Ibex Medical Analytics, a global leader in artificial intelligence (AI)-based cancer diagnostics. Under the agreement, the companies will jointly develop an embedded image analysis workflow for pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology , the cloud version of Roche’s uPath enterprise ... |
| 10/18/2021 |
Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care |
tncontentexchange.com |
Expanded menu of innovative AI-powered decision support tools benefits pathologists and patients through enhanced quality of diagnosis - Joint development to distribute an embedded image analysis workflow for pathologists to seamlessly access Ibex's AI algorithms using NAVIFY Digital Pathology - Builds on Roche's Digital Pathology Open Environment, expanding the company's commitment to improving patient outcomes and advancing personalised healthcare through innovation SANTA CLARA, Calif., Oct. 18, 2021 /PRNewswire/ -- Roche (SIX: RO ... |
| 10/18/2021 |
Inspirata Releases Latest Software and New Partnerships at Pathology Visions 2021 |
Globe Newswire |
Las Vegas, NV / Tampa, FL, Digital pathology and cancer informatics provider Inspirata is proud to announce their latest software release. At Pathology Visions 2021, Inspirata will showcase the new capabilities of Dynamyx release v2.4.0, including patient tracking across multiple systems, PACS/VNA integration automation, DICOM enhancements for multiple vendors, and improved cybersecurity and patient safety measures.“I am super excited and can’t wait to show Pathology Visions attendees all ... |
| 10/18/2021 |
Inspirata Releases Latest Software and New Partnerships at Pathology Visions 2021 |
forextv.com |
Las Vegas, NV / Tampa, FL, Oct. 18, 2021 (GLOBE NEWSWIRE) — Digital pathology and cancer informatics provider Inspirata is proud to announce their latest software release. At Pathology Visions 2021, Inspirata will showcase the new capabilities of Dynamyx release v2.4.0, including patient tracking across multiple systems, PACS/VNA integration automation, DICOM enhancements for multiple vendors, and improved cybersecurity and patient safety measures. “I am super excited and can’t wait ... |
| 10/18/2021 |
Roche and Ibex to Collaborate on AI-Based Digital Pathology Applications |
clpmag.com |
... intelligence (AI)-based cancer diagnostics. Under the agreement, the companies will jointly develop an embedded image analysis workflow for pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology, the cloud version of Roche’s uPath enterprise software. Collaborations with AI companies like Ibex are made possible through Roche’s Digital Pathology Open Environment, which allows pathologists to securely access third-party AI ... |
| 10/18/2021 |
Roche Announces PathAI Collaboration For Artificial Intelligence-based Digital Pathology Applications For Improved Patient Care |
tissuepathology.com |
Roche Announces PathAI Collaboration For Artificial Intelligence-based Digital Pathology Applications For Improved Patient Care [Clinical Laboratories] , [Clinical Pathology] , [Digital Pathology News] , [Health Technology Collaboration] , [Image Analysis] , [Laboratory Management & Operations] , [New Digital Imaging Technologies] , [Pathology News] , [Press Release] , [Web/Tech] , [Whole slide] - Artificial Intelligence technology shows promise in advancing pathology imaging, which can benefit cancer patients through more precise diagnosis leading to targeted treatment. - Collaboration with PathAI expands pathologist access ... |
| 10/18/2021 |
Global In Vitro Diagnostics Market Outlook Report 2021 – Digital Pathology with Artificial Intelligence Driving the Path to Precision Oncology – ResearchAndMarkets.com | Financial Buzz |
financialbuzz.com |
... benchmarking of top participants, and key growth opportunities that will shape the industry.Growth Opportunity UniversePOCT Instruments for Diagnosis of Respiratory Infections Direct-to-Consumer (DTC) Testing Services to Address Personalized Genetic Diagnostics Digital Pathology with Artificial Intelligence Driving the Path to Precision Oncology Smart Labs and Total Laboratory Automation for Shorter Testing Turnaround Time Key Topics Covered:1. Strategic ImperativesWhy is it Increasingly Difficult to Grow? The ... |
| 10/15/2021 |
Roche welcomes PathAI into its open digital pathology initiative |
FierceBiotech |
Roche has tapped PathAI for a collaboration that looks to merge artificial intelligence programs with its digital pathology work, with an eye on boosting the Big Pharma’s development of new drugs and companion diagnostic tests.Under a joint distribution agreement, the two companies will work to develop an embedded image analysis program based on PathAI’s algorithms, which will run through Roche’s cloud-based uPath enterprise software .The ... |
| 10/15/2021 |
Proscia touts study showing digital pathology software detected melanoma - MedCity News |
MedCity News |
Not long after Paige cinched FDA clearance for its algorithm to flag potentially cancerous lesions, another digital pathology startup is touting the results of a study claiming its deep learning technology can detect melanoma with a high degree of accuracy.Philadelphia-based Proscia shared the results of a prospective study testing its DermAI software on skin biopsies from two different laboratories. It found that its AI detected melanoma in situ ... |
| 10/15/2021 |
Health tech giant Philips launches new digital pathology platform |
MobiHealthNews |
Photo by Royal Philips Dutch health tech company Royal Philips today introduced its new enterprise-wide digital pathology platform called IntelliSite. The product features a suite of scalable software tools designed to streamline workflows, enhance diagnostic confidence, facilitate collaboration, integrate artificial intelligence (AI) and increase the efficiency of pathology labs, Philips said in its announcement . IntelliSite can be deployed in labs both small and large with its ability to conduct ... |
| 10/15/2021 |
PathAI and Roche team up to push adoption of digital pathology tech |
MobiHealthNews |
... Äôs uPath software, with a focus on immuno-oncology for the treatment of multiple types of cancers. WHY IT MATTERS PathAI is pitching the partnership as a way to push adoption of AI-powered digital pathology tech in labs, which it argues has been slow because the digital pathology industry is fragmented across different software, hardware and algorithm providers. "This collaboration brings together all of the components required to deliver ... |
| 10/15/2021 |
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care |
Globe Newswire |
... benefit cancer patients through more precise diagnosis leading to targeted treatment.- Collaboration with PathAI expands pathologist access to innovative AI-powered technology to support companion diagnostic and drug development programs.- Builds on Roche’s Digital Pathology Open Environment, expanding the company’s commitment to improving patient outcomes and advancing personalised healthcare through innovationBasel, 15 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered an ... |
| 10/15/2021 |
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care |
roboticulized.com |
... benefit cancer patients through more precise diagnosis leading to targeted treatment. - Collaboration with PathAI expands pathologist access to innovative AI-powered technology to support companion diagnostic and drug development programs. - Builds on Roche’s Digital Pathology Open Environment, expanding the company’s commitment to improving patient outcomes and advancing personalised healthcare through innovation Basel, 15 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered ... |
| 10/15/2021 |
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care |
roche.com |
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care - Artificial Intelligence technology shows promise in advancing pathology imaging, which can benefit cancer patients through more precise diagnosis leading to targeted treatment. - Collaboration with PathAI expands pathologist access to innovative AI-powered technology to support companion diagnostic and drug development programs. - Builds on Roche’s Digital Pathology Open Environment, expanding the company’s commitment to ... |
| 10/15/2021 |
Roche announces collaboration with PathAI |
indianewsrepublic.com |
... for pathology. Based on the development and distribution agreement, the two companies will jointly develop an implantable image analysis workflow for pathologists. This workflow gives you access to PathAI image analysis algorithms within NAVIFY Digital Pathology , the cloud version of Roche’s uPath enterprise software. This collaboration is made possible through Roche’s Digital Pathology Open Environment. This gives pathologists secure access to third-party AI-powered technologies along with ... |
| 10/15/2021 |
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care - Scientific Technology News |
scientifictechnologynews.com |
... benefit cancer patients through more precise diagnosis leading to targeted treatment. Collaboration with PathAI expands pathologist access to innovative AI-powered technology to support companion diagnostic and drug development programs. Builds on Roche’s Digital Pathology Open Environment, expanding the company’s commitment to improving patient outcomes and advancing personalised healthcare through innovation Basel, 15 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered ... |
| 10/15/2021 |
Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care |
blogspot.com |
... benefit cancer patients through more precise diagnosis leading to targeted treatment. Collaboration with PathAI expands pathologist access to innovative AI-powered technology to support companion diagnostic and drug development programs. Builds on Roche’s Digital Pathology Open Environment, expanding the company’s commitment to improving patient outcomes and advancing personalised healthcare through innovation Basel, 15 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered ... |